Sources: Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B (Bloomberg)
Isomorphic Labs is discussing a new round that would price it at $40 billion or more.
The Bloomberg-sourced note says the talks are early. Isomorphic Labs was spun out of Google DeepMind and works on AI drug discovery. The report does not state how much it aims to raise or name participating investors. Techmeme's note
The Bloomberg-sourced note says the talks are early. Isomorphic Labs was spun out of Google DeepMind and works on AI drug discovery. The report does not state how much it aims to raise or name participating investors. Techmeme's note
score 8